
Shenzhou-20 Crew Advances Science Aboard China’s Space Station
From Shenzhou-20’s cell research to microgravity combustion tests, see how China’s orbiting station is advancing space science and health insights.
My Global News: Voices of a New Era
🌍 Stay Ahead, Stay Global 🚀
From Shenzhou-20’s cell research to microgravity combustion tests, see how China’s orbiting station is advancing space science and health insights.
At the third China International Supply Chain Expo, biotech and pharma firms unveiled modular supply chains that drive efficiency and global reach for suppliers and clients.
Researchers in the Chinese mainland launch PlantGPT, an AI-driven Q&A system for plant functional genomics, promising precise insights to accelerate biotech research worldwide.
New sweat-sensing patch tracks Parkinson’s biomarkers in real time, offering a non-invasive tool for early diagnosis and continuous monitoring.
Biogen has launched Tofersen, the Chinese mainland’s first gene-targeted therapy for SOD1-ALS, offering hope by slowing motor neuron damage in a disease fatal within 3-5 years.
China’s drug regulator approves the country’s first domestically developed 9-valent HPV vaccine, targeting nine strains to boost protection against cervical cancer.
The Chinese mainland greenlights Cecolin 9, its first domestically developed nine-valent HPV vaccine, promising over 98% protection and an easier two-dose schedule for teens.
A team of researchers aboard China Space Station discovered Niallia tiangongensis, a novel microbe thriving in microgravity, opening doors for biotech innovations and astrobiology.
Australian scientists unveil PROTEUS, a mammalian cell-based protein evolution platform that accelerates gene therapy, disease research and next-gen treatments.
China’s vaccine advances—from HPV and Ebola breakthroughs to WHO prequalification—are driving a global immunization shift with innovation, oversight, and digital tools.